Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from External Customer [Line Items]

Contract with customer balances

The following table provides information about contract assets from contracts with customers (in millions):

	Balance Sheet Location	December 31, 2021		December 31, 2020
Short-term contract assets	Prepaid expenses and other current assets	$	40.2	$	19.7

Product

Revenue from External Customer [Line Items]

Disaggregation of revenue

We generated net sales in the following geographic locations(1) during each of the periods presented below (in millions):

	Year Ended
	December 31, 2021		December 31, 2020		December 31, 2019
U.S.	$	2,565.9	$	2,579.0	$	2,360.3
Europe(2)	1,393.0		1,350.6		1,335.8
All other countries(3)	179.8		158.6		173.8
Total net sales	$	4,138.7	$	4,088.2	$	3,869.9

(1)    The net sales by geography is derived from the location of the entity that sells to a third party.

(2)    Includes Ireland net sales of $23.7 million, $29.8 million, and $23.4 million for the years ended December 31, 2021, December 31, 2020, and December 31, 2019, respectively.

(3)    Includes revenue generated primarily in Mexico, Australia, and Canada.

Product Category

The following is a summary of our net sales by category (in millions):

	Year Ended
	December 31, 2021		December 31, 2020		December 31, 2019
CSCA(1)
Upper respiratory	$	483.1	$	505.8	$	529.3
Digestive health	475.1		471.3		429.2
Pain and sleep-aids	405.4		434.5		390.9
Nutrition	401.9		388.3		395.3
Oral care	311.9		288.2		111.7
Healthy lifestyle	297.7		352.4		356.1
Skincare and personal hygiene	219.2		200.6		191.3
Vitamins, minerals, and supplements	31.7		27.0		28.6
Animal health	—		—		43.7
Other CSCA(2)	67.1		24.9		11.6
Total CSCA	2,693.1		2,693.0		2,487.7
CSCI
Skincare and personal hygiene	394.3		351.8		371.6
Upper respiratory	226.2		255.1		276.8
Vitamins, minerals, and supplements	217.4		201.0		180.2
Pain and sleep-aids	201.8		190.4		167.9
Healthy lifestyle	179.3		165.4		173.8
Oral care	95.8		97.8		51.2
Digestive health	38.4		26.5		27.1
Other CSCI(3)	92.4		107.2		133.6
Total CSCI	1,445.6		1,395.2		1,382.2
Total net sales	$	4,138.7	$	4,088.2	$	3,869.9

(1)    Includes net sales from our OTC contract manufacturing business.

(2)    Consists primarily of product sales and royalty income related to supply and distribution agreements, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

(3)    Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.